Publications

Filter by type

Filter by year

Showing all years

What is psoriasis? – Perception and assessment of psoriasis among the German population

R. Sommer1, U. Mrowietz2, M. Alexander Radtke1, I. Schäfer1, R. von Kiedrowski3, K. Strömer4, A. Enk5, J. Maul6, K. Reich7, N. Zander1, M. Augustin1

1Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany

2Department of Dermatology, Venereology and Allergology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany

3Dermatology Practice Selters, Selters/Westerwald, Germany
4Group Practice for Dermatology and Allergology, Mönchengladbach, Germany

5Department of Dermatology, University Medical Center Heidelberg, Heidelberg, Germany
6Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
7Dermatologikum Hamburg, Hamburg, Germany

J Dtsch Dermatol Ges. 2018 Jun;16(6):703-710

 

Delivery of health care to psoriasis patients plays an important role in the field of dermatology. Following the 2014 WHO resolution and the 2016 WHO glo- bal report, there has been an increase in the awareness of psoriasis among the general public. However, the perception of psoriasis by the general population remains uncle- ar. The goal of the present study was to investigate the perception and assessment of psoriasis among the German population.

Was ist Schuppenflechte? – Wahrnehmung und Bewertung der Psoriasis in der deutschen Bevölkerung

R. Sommer1, U. Mrowietz2, M. Alexander Radtke1, I. Schäfer1, R. von Kiedrowski3, K. Strömer4, A. Enk5, J. Maul6, K. Reich7, N. Zander1, M. Augustin1

1Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany

2Department of Dermatology, Venereology and Allergology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany

3Dermatology Practice Selters, Selters/Westerwald, Germany
4Group Practice for Dermatology and Allergology, Mönchengladbach, Germany

5Department of Dermatology, University Medical Center Heidelberg, Heidelberg, Germany
6Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
7Dermatologikum Hamburg, Hamburg, Germany

J Dtsch Dermatol Ges. 2018 Jun;16(6):703-710

 

DieVersorgungderPsoriasisvulgarisnimmtinderDermatologieeinen wichtigen Stellenwert ein. Im Zuge der WHO-Resolution 2014 und des WHO Global Reports 2016 hat die öffentliche Aufmerksamkeit für die Psoriasis zugenommen. Un- klar ist, wie Psoriasis in der Allgemeinbevölkerung wahrgenommen wird. Ziel ist die Erfassung der Wahrnehmung und Bewertung von Psoriasis in der Bevölkerung.

Quality of Life in Adolescent Boys with Idiopathic Short Stature: Positive Impact of Growth Hormone and Aromatase Inhibitors

M. Bullinger1, J. Bloemeke2, V. Mericq3, R. Sommer1, X. Gaete3, J. L. Ross4, Y M. Yu5, J. Permuy6, P. Gagliardi6, Y. L. Damaso6, N. Mauras6

1University Clinic Hamburg-Eppendorf, Hamburg, Germany

2University Clinic Hamburg-Eppendorf, Hamburg, Germany, j.bloemeke@uke.de

3Division of Endocrinology, University of Santiago, Santiago, Chile

4Division of Endocrinology, Nemours Children's Health System, Philadelphia, Pennsylvania, USA

5Division of Endocrinology, Nemours Children's Health System, Orlando, Florida, USA

6Division of Endocrinology, Nemours Children's Health System, Jacksonville, Florida, USA

Horm Res Paediatr. 2018;90(6):381-392

 

The combination of growth hormone (GH) and aromatase inhibitors (AI) improves linear growth in severely short adolescent boys; however, the effects of this interven- tion on quality of life (QoL) are unknown. This study assesses whether GH, AI, or their combination impacts the QoL of ad- olescent males with idiopathic short stature (ISS) from both the adolescent and the parent perspective.

Children's psychosocial functioning and parents' quality of life in paediatric short stature: The mediating role of caregiving stress

N. Silva1,2, M. Bullinger1, R. Sommer1, A. Rohenkohl1, S. Witt1, J. Quitmann1

1Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

2Cognitive and Behavioral Center for Research and Intervention, Faculty of Psychology and Education Sciences, University of Coimbra, Coimbra, Portugal

Clin Psychol Psychother. 2018 Jan;25(1):e107-e118

 

On the basis of the multidimensional model of the caregiving process, this study aimed (a) to compare the levels of quality of life (QoL) and psychological problems of children with short stature and the levels of caregiving stress and QoL of their parents, between diagnostic, treatment, and current height deviation groups, and (b) to examine the direct and indirect links, via caregiving stress, between children's psychosocial functioning and their parents' QoL.

The psychometric evaluation of the quality of life in short stature youth (QoLISSY) instrument for German children born small for gestational age

R. Sommer1, J. Blömeke2, M. Bullinger2, J. Quitmann2

1Department of Medical Psychology, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. r.sommer@uke.de

2Department of Medical Psychology, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany

J Endocrinol Invest. 2018 Oct;41(10):1185-1191

 

This study aimed to validate the disease-specific “quality of life in short stature youth (QoLISSY)-instrument” that assessesQuery the health-related quality of life (HrQoL) in German children and adolescents diagnosed as small for gestational age (SGA) in a patient and parent report.

Establishing priorities for psychological interventions in pediatric settings: A decision- tree approach using the DISABKIDS-10 Index as a screening instrument

N. Silva1,2, M. Bullinger2, H.a Moreira1, M. Cr. Canavarro1, C. Carona1,3

1Cognitive and Behavioral Center for Research and Intervention, Faculty of Psychology and Education Sciences of the University of Coimbra, Coimbra, Portugal

2Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

3Federation of Portuguese Cerebral Palsy Associations, Cerebral Palsy Association of Coimbra, Coimbra, Portugal

PLoS One. 2018;13(5):e0198402

 

Most children and adolescents with chronic health conditions have impaired health-related quality of life and are at high risk of internalizing and externalizing problems. However, few patients present clinically significant symptoms. Using a decision-tree approach, this study aimed to identify risk profiles for psychological problems based on measures that can be eas- ily scored and interpreted by healthcare professionals in pediatric settings.

Development and validation of the Patient Benefit Index for peripheral arterial disease

N. Zander1, E-B. Demirel1, M. Augustin1, R. Sommer1, E. S. Debus2, P. Breuer3, C. Blome1

1Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany

2Department of Vascular Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany

3Department of Vascular and Endovascular Surgery, Asklepios Klinik Wandsbek, Hamburg, Germany

Vasa. 2018 Apr;47(3):219-226

 

The aim of this study was to develop and validate a specific Patient Benefit Index (PBI) version for the treatment of peripheral arterial disease (PAD).

 

Differences between patient- and proxy-reported HRQoL using the Wound-QoL

R. Sommer, Dr. Rer. Biol. Hum.1 ; C. Hampel-Kalthoff2; B. Kalthoff2; C. Neht, MSc1; E. Scherfer2; M. Winkler, Dr.2, C. Blome, Dr. Phil.1

1German Center for Health Services Research in Dermatology (CVderm), Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany

2ORGAMed Dortmund GmbH, Dortmund, Germany

Wound Repair Regen. 2018 May;26(3):293-296

 

The purpose of this study was to examine the patient- and proxy-report agreement on the Wound-quality of life (QoL) questionnaire to assess health-related QoL in patients with chronic wounds.

Umsetzung der WHO Psoriasis - Resolution in die Öffentlichkeit: ein bundesweites Programm gegen Stigmatisierung bei chronisch sichtbaren Hauterkrankungen

M. Augustin, U. Mrowietz, C. Luck-Sikorski, R. von Kiedrowski, S. Schlette, M. Radtke, SM. John, A. Zink, N. Suthakaran, R. Sommer (2018, October).

17. Deutscher Kongress für Versorgungsforschung 2018: P230

HrQoL effects of growth-hormone treatment in short statured youth: A controlled prospective study

M. Bullinger, J. Bloemeke, N. da Silva, J. Quitmann, H-G. Dörr, The German QOLISSY Prospective Group (2018, October). 

Poster session presented at the ISOQOL 25th Annual Conference, Dublin, Ireland.